Literature DB >> 24945326

Reversible corpus callosum splenial lesion due to steroid therapy.

Banu Aksu1, Serpil Kurtcan, Alpay Alkan, Ayse Aralasmak, Faruk Oktem.   

Abstract

Reversible corpus callosum splenial (CCS) lesions are rare findings and usually detected incidentally. We presented a case of 15-year-old boy with a diagnoses of nephrotic syndrome. He was referred for neuropsychiatric symptoms following dose reduction on steroid treatment. Brain magnetic resonance imaging (MRI) revealed a focal lesion in the CCS, hyperintense on T2 and FLAIR and hypointense on T1 images with diffusion restriction on apparent diffusion coefficient map. Follow-up MRI 3 weeks later showed complete resolution of the lesion. It was probably result of focal intramyelinic edema due to excytotoxic mechanisms and/or arginine-vasopressin release.
Copyright © 2014 by the American Society of Neuroimaging.

Entities:  

Keywords:  Corpus callosum splenial lesion; diffusion weighted imaging; steroid

Mesh:

Substances:

Year:  2014        PMID: 24945326     DOI: 10.1111/jon.12128

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  3 in total

1.  Diffusion MRI features of acute encephalopathy due to stopping steroid medication abruptly in congenital adrenal hyperplasia.

Authors:  Asli Serter; Alpay Alkan; Demet Demirkol
Journal:  Ann Indian Acad Neurol       Date:  2015 Jul-Sep       Impact factor: 1.383

2.  Statistical Analysis of the Apparent Diffusion Coefficient in Patients with Clinically Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion Indicates That the Pathology Extends Well beyond the Visible Lesions.

Authors:  Yang Qing; Wang Xiong; Huang Da-Xiang; Zhu Juan; Wang Fei; Yu Yong-Qiang
Journal:  Magn Reson Med Sci       Date:  2019-04-05       Impact factor: 2.471

3.  Reversible splenial lesion syndrome in children: clinical analysis and summary of a case series.

Authors:  Xinying Zhang; Na Chen; Jiamin Guo; Shuwei Li; Jiaming Xu; Weiwei Zhu; Aihua Ma
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.